forex

Jubilant Life Sciences – Q3 & 9M’FY19 Results

New  Delhi, February 02, 2019:  JUBILANT REPORTSRECORD PERFORMANCE IN Q3’FY19 Revenue up 15% YoY to Rs. 2,377 Crore; EBITDA up…

6 years ago

Granules India’s Revenue from operation increases by 14% to INR 411 Cr.

Mumbai, February 09, 2018: Granules India Ltd., a growing pharmaceutical manufacturing company, announced today financial results for its third quarter…

7 years ago